Compositions and methods of treating disease with FGFR fusion proteins

Details for Australian Patent Application No. 2006272759 (hide)

Owner Five Prime Therapeutics, Inc.

Inventors Qin, Minmin; Wu, Ge; Lee, Ernestine; Wong, Justin; Sadra, Ali; Hollenbaugh, Diane; Hestir, Kevin; Williams, Lewis T.; Zhang, Hongbing; Doberstein, Stephen; Bosch, Elizabeth

Agent Pizzeys

Pub. Number AU-B-2006272759

PCT Pub. Number WO2007/014123

Priority 60/701,479 22.07.05 US; 60/729,401 21.10.05 US; 60/800,005 15.05.06 US; 60/757,398 10.01.06 US

Filing date 24 July 2006

Wipo publication date 1 February 2007

Acceptance publication date 12 January 2012

International Classifications

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

C07K 14/71 (2006.01) Peptides having more than 20 amino acids

Event Publications

21 February 2008 PCT application entered the National Phase

  PCT publication WO2007/014123 Priority application(s): WO2007/014123

12 January 2012 Application Accepted

  Published as AU-B-2006272759

10 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006272760-High drug load formulations and dosage forms

2006272756-Dispenser tray for a vending machine